The brain implant company founded by Elon Musk is on the rise. According to the news served by Reuters, the value of Neuralink exceeded 5 billion dollars. But experts are skeptical that the company’s securities are so popular.Neuralink recently announced that it has received approval to conduct clinical trials to implant chips in the human brain. Prior to that, some acquisitions by bull investors have boosted the company’s value in recent months. It was stated that the firm was worth $2 billion two years ago.
High demand for shares
The demand for Neuralink shares is very high. Pointing out that the implant development process is still in its early stages, experts are skeptical of this popularity. According to analysts, it will take at least 10 years for Musk to get commercial use permission for the brain implant.
Neuralink aims to develop chips that will help people interact with devices with the power of their minds. In 2021, the company had a macaque monkey implanted with a Neuralink chip in its brain to move the cursor on the screen with the power of thought.Neuralink announced on May 25 that it has received approval from the U.S. Food and Drug Administration (FDA) to run its first human clinical trial. The company says recruiting volunteers for clinical trials has yet to begin.
39242
